GNI Group Ltd Sustainability Reports
GNI Group Ltd. is a global biopharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical drugs and biomaterials. Its business segments focus on treating diseases common in Asia, such as liver and idiopathic pulmonary fibrosis, and providing orthobiologics products.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
LEI: 5299005KSTCN0WVJMQ52
FIGI: BBG001SV7XM4
1 reports from 2024 to 2024
